Focus on cost-effectiveness, utility studies `could be a mistake'

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.364, 2002-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Funding of cost-effectiveness studies could cause controversy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 576, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Published cost-effectiveness studies report favourable ICERs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 498, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

By Gerzeli Simone  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Lifetime Cost-Utility Analysis of Patients with Refractory Epilepsy Treated with Adjunctive Topiramate Therapy: Cost-Effectiveness in Refractory Epilepsy

By Maltoni S.   Messori A.  

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 225-232

Adis International

Access to resources Recommend Favorite

Sensitivity Analysis in Cost-Effectiveness Studies: From Guidelines to Practice

By Jain Rahul  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 297-314

Adis International

Access to resources Recommend Favorite